Heinkel AG
Heinkel AG correction

Correction Ad-hoc-announcement processed and transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Corrected announcement on behalf of the issuer: In the ad hoc announcement on November 30, 8.24 a.m., the second paragraph, third sentence, instead of: “Profits prior to taxation were as of September 30, 0.9 mil DM, compared with 2.3 mil DM to last year figures during the same time period.” it must read: “Profits after taxation as of September 30, are 0.9 mil DM, compared with last year figures of 2.3 mil DM during the same time period.”. The complete corrected announcement is: A Weak Pharmaceutical Economic Trend Puts Pressure on HEINKEL AG Results Betigheim-Bissingen. November 28, 2001 Strong governmental authorization practices, administrative price decreases, and the State ordered infiltration of the patent laws have lead the pharmaceutical industry into a severe since insecurity. The results of this is a strong decline in investments in the industry generally, and in turn is also clearly reflected in this years HEINKEL AG numbers. As the worlds market leader in the area of Centrifuges, HEINKEL AG distributes a major portion of its products to this market segment. With a turnover of 47.3 mil DM during the first 9 months we still lie within last years levels (2000: 47.6 mil DM). Noticeable however, are the present market weaknesses in our results. Profits after taxation as of September 30, are 0.9 mil DM, compared with last year figures of 2.3 mil DM during the same time period. The company assumes that our gain prognosis of 64 mil DM (2000 66.2 mil Dm) is to be narrowly reached by the end of the year. The result of our general business activity will be -3,5 mil, DM (2000: +6.3 mil. DM), included in this are the 1 mil. DM expected from cost the reduction measures taken. An actual market recovery is only foreseen during the second half of the coming year. The Board expects during 2002, a slight turnover reduction to take place, and in turn, a more positive result also, thanks to cost reduction measures taken. The Board Tel: 07142-356-101 http://www.heinkel.de Fax: 07142-356-109 end of ad-hoc-announcement (c)DGAP 11.12.2001 ——————————————————————————– WKN: 605900; ISIN: DE0006059009; Index: SDax Listed: Amtlicher Handel in Frankfurt(SMAX); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart 110834 Dez 01